1. Effect of SGLT-1/2 inhibition on mitochondrial dysfunction in left atrial remodeling during HFpEF. (25th November 2020) Authors: Bode, D; Semmler, L; Hegemann, N; Primessnig, U; Wakula, P; Pieske, B.M; Messroghli, D; Heinzel, F.R; Hohendanner, F Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of doxorubicin and ibrutinib on atrial arrhythmogenity: ex-vivo assessment in human myocardium. (3rd October 2022) Authors: Berger, Y; Primessnig, U; Huettemeister, J; Parwani, A S; Boldt, L H; Pieske, B; Falk, V; Grubitzsch, H; Blaschke, F; Heinzel, F R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P311In-vivo and cellular left atrial function in an experimental model of heart failure with preserved ejection fraction. (19th March 2018) Authors: Hohendanner, F; Bode, D; Primessnig, U; Guthof, T; Wakula, P; Pieske, B; Heinzel, F Journal: Europace Issue: Volume 20(2018)Supplement 1 Page Start: i46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P680Na+/Ca2+ exchanger (NCX) function and diastolic Ca2+ leak in a model of heart failure with preserved ejection fraction. (15th July 2014) Authors: Primessnig, U; Hoell, A; Wakula, P; Pieske, BM; Heinzel, FR Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗